Login / Signup

Public Preference for Financing Preventive Vaccines in Health Shocks: The Case of COVID-19 Vaccines in a Middle-Income Country.

Najmeh MoradiLeila ZareiNarges HajimoladarvishZahra MeshkaniMarzieh ZanganehJafar BabapourKamran Bagheri Lankarani
Published in: PharmacoEconomics - open (2024)
Regardless of country of origin of COVID-19 vaccines, vaccination is very important for the Iranian people, and the majority of respondents in our study showed an inclination to contribute to vaccine funding, from partial to full user fees, to achieve higher protection against COVID-19 disease. Hence, ensuring timely access to vaccines during health crises such as pandemics is imperative, as it saves lives and reduces the economic burden of disease. This commitment from the health system can be supported by financial contributions from the general public. In this regard, considering public preferences is strongly advised to policymakers.
Keyphrases
  • coronavirus disease
  • healthcare
  • mental health
  • sars cov
  • public health
  • respiratory syndrome coronavirus
  • physical activity
  • health information
  • risk assessment
  • human health
  • young adults